by Roshan Yoganathan | Jun 5, 2012
The last time I blogged here, I introduced the idea of using biomaterials to monitor and sense changes in various physiological environments. Having materials in the body that can do this allows for real-time feedback regarding changes in the body. The use of...
by Paul Krzyzanowski | May 16, 2012
Commercialization plenary summary: part 4 of 4 The last speaker of the commercialization plenary at the Till and McCulloch Meetings earlier this month was Dr. Stephen Minger from GE Healthcare, who shared GE’s perspective regarding the therapeutic and research...
by David Kent | May 8, 2012
The final day of the 2012 Till and McCulloch Meetings was packed with great science, but a common theme definitely emerged – technological advances are changing the way we think about and perform scientific research. Keynote speaker Helen Blau issued a warning...
by Lisa Willemse | Apr 24, 2012
An interview with Till & McCulloch Award winner, Dr. Aaron Schimmer, whose paper, entitled “Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia,” published in Cancer Cell, November 2011, was selected by committee as...
by Angela C. H. McDonald | Apr 17, 2012
Most research on stem cells involves the manipulation of gene expression, to some degree or another. During stem cell differentiation, the expression of specific genes orchestrates the choices cells make along the path from stem cell to adult cell — a process...
Comments